Development and validation of a nomogram for predicting survival in patients with malignant myofibroblastic tumor
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5668
Abstract: Malignant myofibroblastic tumors are a rare group of soft tissue sarcomas, for which a prognosis prediction model is lacking. Based on the Surveillance, Epidemiology, and End Results (SEER) database and cases from Nanjing Drum Tower… read more here.
Keywords: development validation; nomogram predicting; patients malignant; malignant myofibroblastic ... See more keywords